The 7 analysts offering 12-month price forecasts for Rigel Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 15.00 and a low estimate of 1.20. The median estimate represents a +63.27% increase from the last price of 1.23.
The current consensus among 7 polled investment analysts is to Hold stock in Rigel Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Nov 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.